Health and Wellness Informatics News
The glucose monitor program plans to work on diabetes. The patients can test themselves for diabetes and send data remotely. This data can monitor their glucose levels.
Evernorth is a subsidiary of Cigna. It plans to build upon its diabetes program. The program will also add more devices with better technology to the system. However, the company wants diabetes patients to manage their health effectively. It will also check data for the glucose monitor.
However, the program solely represents care for diabetes patients. The company will cover continuous glucose monitor. The company will also get data for many diabetic patients. This is beneficial for the healthcare system.
The glucose monitor is a piece of medical equipment. This is also helpful for the diabetes community. 2017 was the year of the launch of the diabetes care value program. But 2020 was the year when Cigna rebranded its whole health service business line.
The number of patients with diabetes is increasing daily. 37 million diabetic people are living in the US alone. Shockingly there are 96 million people with prediabetes. However, they are 11 and 38 percent of the US population. It is a big number. The healthcare system is also often under pressure to handle this patient inflow.
The poor communities have more incidence of diabetes. The American Diabetes Association found this incidence. Diabetes is often a disease that goes unrecognized. The body cannot make insulin to break down glucose. This also has many serious complications for the human body.
The ADA mentioned that a glucose monitor is essential for diabetic checkups. They continuously monitor the ambulatory glucose profile. It also gives a clear picture of insulin and glucose levels. These devices send data continuously to the concerned device. The flexibility allows patients to self-test many times a day.
Many healthcare systems all around the world are fighting against diabetes. Diabetes reversal is an important field of study. Many collaborations are also focusing on the reversal of diabetes. Many grants and funding are being continuously awarded to these partnerships. This is important for every diabetic patient in the US and the world.